Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amira Pharmaceuticals Inc.

Division of Bristol-Myers Squibb Co.
www.amirapharm.com

Latest From Amira Pharmaceuticals Inc.

From Inception, Tempest Plans To Kick Up IO Storm

Emerging Company Profile: Spinning out of Versant Ventures’ Inception Sciences, San-Francisco-based development-stage biotech Tempest Therapeutics Inc. completes $70m Series B round to advance small molecules that modulate anti-tumor immunity pathways.

Financing StartUps and SMEs

J&J’s $30bn For Actelion Buys Immediate And Longer-Term Value

In this tale of two companies, it's the best of times and the best of times. J&J gets immediate value by acquiring Actelion's blockbuster PAH franchise and its late-stage pipeline, while its stake in an Actelion spinout offers longer-term potential.

M & A Deals

Here To Stay: Inception Sciences Shows Why Build-To-Buy Works

Born at a time when venture capital found few exit opportunities for early-stage companies, build-to-buy helped mitigate the risk in investing in uncharted science. But the model is flourishing even in this period of wider capital options.

BioPharmaceutical Strategy

Versant Launches Inception IBD, A New Company With Old Roots

Versant and Celgene have partnered again to launch a build-to-buy biotech, this time focusing on inflammatory bowel disease.

BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bristol-Myers Squibb Co.
  • Senior Management
  • Robert F Baltera, Jr., CEO
    Michael V Swanson, CFO
    Peppi Prasit, PhD, CSO
  • Contact Info
  • Amira Pharmaceuticals Inc.
    Phone: (858) 228-4650
    9535 Waples St.
    Ste. 100
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register